Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition

Pediatric Transplantation

Volumn 19, Issue 4, 2015, Pages E97-E100

  Sakamoto, Kenichi ^a   Imamura, Toshihiko ^a   Osone, Shinya ^a   Nishimura, Ayako ^a   Nishida, Masashi ^a   Ishida, Hiroyuki ^a   Hosoi, Hajime ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

C4d deposition; complements system; hematopoietic stem cell transplantation; thrombotic microangiopathy

Indexed keywords

COMPLEMENT COMPONENT C4D; CREATININE; CYTARABINE; DANAPAROID; DEXAMETHASONE; ECULIZUMAB; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; LACTATE DEHYDROGENASE; MELPHALAN; METHOTREXATE; MITOXANTRONE; MYCOPHENOLATE MOFETIL; RECOMBINANT THROMBOMODULIN; TACROLIMUS; BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; COMPLEMENT INHIBITOR; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTERIOLE; ARTICLE; B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; BACTERIAL INFECTION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENDOTHELIUM CELL; ERYTHROPHAGOCYTOSIS; GLOMERULUS BASEMENT MEMBRANE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LOW DRUG DOSE; MALE; MYELOABLATIVE CONDITIONING; PROTEINURIA; RENAL ARTERIOLE; SCHOOL CHILD; SHORT COURSE THERAPY; STAINING; SWELLING; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY; WHOLE BODY RADIATION; ADVERSE EFFECTS; BIOPSY; CHEMISTRY; IMMUNOLOGY; KIDNEY; KIDNEY ARTERY; LEUKEMIA, MYELOID, ACUTE; METABOLISM; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, HUMANIZED; BIOMARKERS; BIOPSY; CHILD; COMPLEMENT C4B; COMPLEMENT INACTIVATING AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY; LEUKEMIA, MYELOID, ACUTE; MALE; PEPTIDE FRAGMENTS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; RENAL ARTERY; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

EID: 84929046376     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12450     Document Type: Article

References (10)

1. Laskin BL, Goebel J, Davies SM, Jodele S,. Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011: 118: 1452-1462.
2. Batts ED, Lazarus HM,. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant 2007: 40: 709-719.
3. Jodele S, Licht C, Goebel J, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood 2013: 122: 2003-2007.
4. Laskin BL, Maisel J, Goebel J, et al. Renal arteriolar C4d deposition: A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 2013: 96: 217-223.
5. Miyachi M, Watanabe E, Watanabe N, et al. MRD detection of leukemia relapse using HLA typing by FACS in combination with FISH after mismatched allogeneic stem cell transplantation. Pediatr Transplant 2014: 18: E180-184.
6. Troxell ML, Pilapil M, Miklos DB, Higgins JP, Kambham N,. Renal pathology in hematopoietic cell transplantation recipients. Mod Pathol 2008: 21: 396-406.
7. Hayde N, Bao Y, Pullman J, et al. The clinical and molecular significance of C4d staining patterns in renal allografts. Transplantation 2013: 95: 580-588.
8. Jodele S, Davies SM, Lane A, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: A study in children and young adults. Blood 2014: 124: 645-653.
9. Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013: 368: 2169-2181.
10. Jodele S, Fukuda T, Vinks A, et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2014: 20: 518-525.